Investors Pick Up SAGE Even Lower Than Its Secondary Stock Offering
May 18, 2018 at 15:30 PM EDT
Looking back to 98 days ago, Sage Therapeutics Inc (SAGE) priced a 3,506,098 share secondary stock offering at $164.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
